Comments on: Vertex Fending Off Competitors By Treating the Toughest Patients With Hepatitis C http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/ Business + Technology in the Exponential Economy Sat, 21 Nov 2009 22:30:41 -0600 http://wordpress.org/?v=2.8.6 hourly 1 By: Maria Becker http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-79149 Maria Becker Wed, 02 Sep 2009 14:36:56 +0000 http://www.xconomy.com/?p=4742#comment-79149 My husband tried to get into this clinical trial but he was already on Interferon for the 3rd time so they wouldn't take him in... Please hurry and get it on the market, we would have been willing to pay if it meant he could have gotten into this study. We have heard all good things about it. My husband tried to get into this clinical trial but he was already on Interferon for the 3rd time so they wouldn’t take him in… Please hurry and get it on the market, we would have been willing to pay if it meant he could have gotten into this study. We have heard all good things about it.

]]> By: Luke Timmerman http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-71993 Luke Timmerman Sat, 25 Jul 2009 01:48:33 +0000 http://www.xconomy.com/?p=4742#comment-71993 Patients who want up-to-date information on Vertex clinical trials can check here. http://www.vrtx.com/current-projects/Clinical-Trials.html Clinical Trials & Medical Information: Phone: 877-634-VRTX 617-444-6777 For information on other open clinical trials for Hepatitis C, check here: http://clinicaltrials.gov/ Patients who want up-to-date information on Vertex clinical trials can check here.

http://www.vrtx.com/current-projects/Clinical-Trials.html
Clinical Trials & Medical Information:
Phone:
877-634-VRTX
617-444-6777

For information on other open clinical trials for Hepatitis C, check here:

http://clinicaltrials.gov/

]]> By: JAMES T LAWSON http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-71991 JAMES T LAWSON Sat, 25 Jul 2009 01:11:23 +0000 http://www.xconomy.com/?p=4742#comment-71991 HOW CAN I GET INTO ONE OF THESE CLINICAL TESTS,MY SON WHO LIVES IN THAILAND FAILED IN THE FIRST COURSE OF TREATMENTS AND REFUSES ANYTHING THAT MADE HIM FEEL AS MISERABLE AS HE DID FOR 48 WEEKS. HOW CAN I GET INTO ONE OF THESE CLINICAL TESTS,MY SON WHO LIVES IN THAILAND FAILED IN THE FIRST COURSE OF TREATMENTS AND REFUSES ANYTHING THAT MADE HIM FEEL AS MISERABLE AS HE DID FOR 48 WEEKS.

]]> By: Janet A http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-70268 Janet A Sun, 12 Jul 2009 12:54:23 +0000 http://www.xconomy.com/?p=4742#comment-70268 Stop playing politics with our lives! I didn't respond as well as hoped with the 48 week treatment and am borderline cirrohis. I need this as well as thousands of patients like me. I would be more than willing to be a guinea pig. I live in fear every time I go to the doctor that my options are getting fewer, but with this treatment, I have tremendous hope for a cure...but the politics! Vertex...please push this thru! Stop playing politics with our lives! I didn’t respond as well as hoped with the 48 week treatment and am borderline cirrohis. I need this as well as thousands of patients like me. I would be more than willing to be a guinea pig. I live in fear every time I go to the doctor that my options are getting fewer, but with this treatment, I have tremendous hope for a cure…but the politics! Vertex…please push this thru!

]]> By: barry senn http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-67916 barry senn Wed, 01 Jul 2009 02:47:01 +0000 http://www.xconomy.com/?p=4742#comment-67916 If there is any way to be a guinea pig in these studies, please someone let me know. thanx Barry in Oregon If there is any way to be a guinea pig in these studies, please someone let me know. thanx Barry in Oregon

]]> By: Vickie Soriano http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-46991 Vickie Soriano Sat, 21 Feb 2009 20:14:47 +0000 http://www.xconomy.com/?p=4742#comment-46991 The FDA are the ones who need to fast track this to approval. I have been watching this for a couple of years now and it looks to me like Vertex is doing everything they can to get this out as quickly as possible. I also understand their caution. We do live in a sue happy society. They need to play by the rules and dot their i s and cross their t s. I am just grateful there is hope on the horizon. The FDA are the ones who need to fast track this to approval. I have been watching this for a couple of years now and it looks to me like Vertex is doing everything they can to get this out as quickly as possible. I also understand their caution. We do live in a sue happy society. They need to play by the rules and dot their i s and cross their t s. I am just grateful there is hope on the horizon.

]]> By: hepatitis c - racing to treat the untreatable « nuts for healthcare: a healthcare blog http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-44639 hepatitis c - racing to treat the untreatable « nuts for healthcare: a healthcare blog Mon, 19 Jan 2009 09:35:44 +0000 http://www.xconomy.com/?p=4742#comment-44639 [...] biotech firm, Vertex Pharmaceuticals (in collaboration with Tibotec, Johnson & Johnson).  They threw all chips on the table when they declared in Aug. 2008 that they would begin a 650-patien... which would target patients who didn’t initially respond to treatment, who responded only [...] [...] biotech firm, Vertex Pharmaceuticals (in collaboration with Tibotec, Johnson & Johnson).  They threw all chips on the table when they declared in Aug. 2008 that they would begin a 650-patien… which would target patients who didn’t initially respond to treatment, who responded only [...]

]]> By: steph http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-41469 steph Sun, 30 Nov 2008 02:02:32 +0000 http://www.xconomy.com/?p=4742#comment-41469 Any free studies available to get into please? Any info. would be appreciated Any free studies available to get into please?
Any info. would be appreciated

]]> By: Vicki DeWitt http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-38888 Vicki DeWitt Sat, 15 Nov 2008 03:18:35 +0000 http://www.xconomy.com/?p=4742#comment-38888 If Vertex new hcv drug has already shown so much potential, isn't there a way to get it approved sooner? If Vertex new hcv drug has already shown so much potential, isn’t there a way to get it approved sooner?

]]> By: Paul http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-35673 Paul Thu, 23 Oct 2008 04:37:10 +0000 http://www.xconomy.com/?p=4742#comment-35673 I guess the drug companies have a dilema! They are currently making billiions of dollars on some people being cured. They are also invested rescue drugs that are required by many doing tx due to reduced white and red blood cell indicators. Now many txers are exending to do 72 weeks which means more units sold. Makes you wonder how hard they're trying, if a cure is found, that gravy train crashes immediately. My sense is that vertex is pushing like crazy because they're not so heavily invested in current tx regimes like Roche and Schering-Plough. I guess the drug companies have a dilema! They are currently making billiions of dollars on some people being cured. They are also invested rescue drugs that are required by many doing tx due to reduced white and red blood cell indicators. Now many txers are exending to do 72 weeks which means more units sold. Makes you wonder how hard they’re trying, if a cure is found, that gravy train crashes immediately. My sense is that vertex is pushing like crazy because they’re not so heavily invested in current tx regimes like Roche and Schering-Plough.

]]> By: ejbSF http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-28719 ejbSF Mon, 15 Sep 2008 04:44:40 +0000 http://www.xconomy.com/?p=4742#comment-28719 For those of us in need - some desperate - for new HCV treatments, this song and dance of study after study for market positioning is just wrong. Telepravir works for a lot of people who haven't responded to previous treatments. GET IT OUT THERE, VERTEX! LIVES ARE ON THE LINE! For those of us in need – some desperate – for new HCV treatments, this song and dance of study after study for market positioning is just wrong. Telepravir works for a lot of people who haven’t responded to previous treatments. GET IT OUT THERE, VERTEX! LIVES ARE ON THE LINE!

]]> By: Vertex Pharma: Lauded for “Tackling Toughest Hep C Non-Responders” with its Teleprevir Candidate. . . . « http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-28001 Vertex Pharma: Lauded for “Tackling Toughest Hep C Non-Responders” with its Teleprevir Candidate. . . . « Tue, 09 Sep 2008 15:18:08 +0000 http://www.xconomy.com/?p=4742#comment-28001 [...] Hep C drug candidate is extending over the Schering drug candidate, boceprivir — do go read it all, but here’s a salient [...] [...] Hep C drug candidate is extending over the Schering drug candidate, boceprivir — do go read it all, but here’s a salient [...]

]]> By: H Blower http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-toughest-patients-with-hepatitis-c/comment-page-1/#comment-27976 H Blower Tue, 09 Sep 2008 06:48:30 +0000 http://www.xconomy.com/?p=4742#comment-27976 Any treatment that has high % of cure without the dreadful side affects leaving one worse than before with or without the disease would be welcome that is a fact Any treatment that has high % of cure without the dreadful side affects leaving one worse than before with or without the disease would be welcome that is a fact

]]>